Journal of Andrology, Vol 20, Issue 5 626-634, Copyright © 1999 by The American Society of Andrology

JOURNAL ARTICLE

The development of male reproductive organ abnormalities after neonatal exposure to tamoxifen is genetically determined

M. Nakai, K. Uchida and C. Teuscher
Department of Veterinary Anatomy, Miyazaki University, Japan.

Responses of the male reproductive organs to neonatal exposures of tamoxifen (Tx) were examined in seven different strains of mice (A/J, AKR/J, BALB/cAnN, C3H/HeJ, C57BL/6J, DBA/ 2J, and FVB/N). Male mice were given daily subcutaneous injections of 2 microg Tx from postnatal day 1 to 5, and the testes, epididymides, ductus deferens, and seminal vesicles were examined at 3 months of age. At necropsy, the testes and seminal vesicles of Tx-treated groups were significantly smaller in size than those of the control groups in all strains. Histologically, the testes of AKR/J, BALB/cAnN, and FVB/N mice showed no abnormality after neonatal treatment with Tx. In contrast, the testes of A/J, C3H/HeJ, C57BL/6J, and DBA/ 2J mice were often necrotic and highly disorganized, with severe inflammation. In the connective tissue surrounding these testes, relatively large arteries were involved in the inflammation, and the vascular lumen was occluded by the thickened tunica interna, suggesting that these testicular changes were due to infarction. Similarly, the epididymides and ductus deferens of Tx-treated A/J, C3H/HeJ, C57BL/6J, DBA/2J, and FVB/N mice showed chronic pyogranulomatous inflammation. The epithelium of the seminal vesicles of Tx-treated A/J, C3H/HeJ, C57BU6J, DBA/2J, and FVB/N mice also exhibited moderate hyperplasia, with squamous metaplasia. These results indicate that neonatal exposure to Tx causes various abnormalities of the male reproductive organs in postpubertal mice, depending on the strains, and suggest that a genetic component plays a major role in determining the phenotypic variation observed.

This article has been cited by other articles:

				P. D. Fillmore, E. P. Blankenhorn, J. F. Zachary, and C. Teuscher Adult Gonadal Hormones Selectively Regulate Sexually Dimorphic Quantitative Traits Observed in Experimental Allergic Encephalomyelitis Am. J. Pathol., January 1, 2004; 164(1): 167 - 175. [Abstract] [Full Text] [PDF]

				M. Colleoni, N. Rotmensz, C. Robertson, L. Orlando, G. Viale, G. Renne, A. Luini, P. Veronesi, M. Intra, R. Orecchia, et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation Ann. Onc., February 20, 2002; 13(2): 273 - 279. [Abstract] [Full Text] [PDF]

				A. Goldhirsch, R. D. Gelber, G. Yothers, R. J. Gray, S. Green, J. Bryant, S. Gelber, M. Castiglione-Gertsch, and A. S. Coates Adjuvant Therapy for Very Young Women With Breast Cancer: Need for Tailored Treatments J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 44 - 51. [Abstract] [Full Text] [PDF]

				J. L. Spearow and M. Barkley Reassessment of models used to test xenobiotics for oestrogenic potency is overdue: Opinion Hum. Reprod., May 1, 2001; 16(5): 1027 - 1029. [Abstract] [Full Text] [PDF]